---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-010941"
form_type: "8-K"
ticker: null
cik: "0001292519"
company_name: "INVIVO THERAPEUTICS HOLDINGS CORP."
filed_at: "2024-02-06T23:59:59+00:00"
generated_at: "2026-06-06T07:49:52.565552+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# InVivo Therapeutics receives Nasdaq delisting notice after Chapter 11 filing; trading to suspend Feb 13

## Summary
- Filed Chapter 11 bankruptcy on Feb 1, 2024.
- Nasdaq notified company of delisting on Feb 2, 2024, per Listing Rules 5101, 5110(b), IM-5101-1.
- Company will not appeal; common stock to be suspended at opening of business on Feb 13, 2024.
- Form 25-NSE will be filed removing securities from Nasdaq listing and registration.

## SEC filing metadata
- accession: 0001104659-24-010941
- form_type: 8-K
- cik: 0001292519
- company_name: INVIVO THERAPEUTICS HOLDINGS CORP.
- filed_at: 2024-02-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1292519/000110465924010941/0001104659-24-010941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1292519/000110465924010941/tm245285d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-010941
- JSON: https://secwatch.observer/filing/0001104659-24-010941.json
- Plain text: https://secwatch.observer/filing/0001104659-24-010941.txt

## Key facts
- Listing & Compliance Notices
  INVIVO THERAPEUTICS HOLDINGS CORP. received a nasdaq delisting notice notice regarding other (rules 5101, 5110(b), IM-5101-1).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Rules: 5101, 5110(b), IM-5101-1
  source text: February 2, 2024, the Company received a notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the Voluntary Petitions and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, Nasdaq had determined that the Company’s common stock will be delisted from Nasdaq. The Company does not intend to appeal this determination and, therefore, it is expected that its common stock will be delisted, which would not affect any actions it may take in bankruptcy. Nasdaq has informed the Company that trading of the C
  evidence_url: https://www.sec.gov/Archives/edgar/data/1292519/000110465924010941/0001104659-24-010941-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.